MetLife's strategic moves and market performance have generated varied responses from stakeholders and Wall Street. The completion of its
$10 billion annuity reinsurance shift has raised questions whether it will redefine the bull case for MET. Conversely, recent share price decline prompted valuation assessments.
Arrowstreet Capital and Invesco Ltd. have increased their holdings in MET, while others such as
Dodge & Cox and
Northwestern Mutual Wealth Management have sold their shares. Q3 results after the reinsurance deal are strong, counteracting concerns of underperformance in the financial sector. Share buybacks amid lower Q3 earnings and a
preferred stock dividends declaration highlighted MET’s capital management philosophy. Despite Q3 earnings surpassing estimates, MET has missed Q2 and Q3 sales expectations causing shares to drop. Taking note of this,
NFLPA executive met with Giants about purchases, while MetLife has recommended that shareholders reject “
Mini-Tender” offer by
Potemkin Limited. A bullish rating from UBS, coupled with MetLife's projected dividend for 2025 being larger than the previous year, maintains optimistic market sentiment.
Metlife MET News Analytics from Sat, 01 Mar 2025 08:00:00 GMT to Sat, 06 Dec 2025 17:26:50 GMT -
Rating 6
- Innovation 4
- Information 8
- Rumor -2
